|
rdfs:label
|
"(RS)-Rosiglitazon"@de
"(RS)-rosiglitazone"@en
"(RS)-rosiglitazone"@fr
"(RS)-rozyglitazon"@pl
"Rosiglitatsoni"@fi
"Rosiglitazon"@id
"Rosiglitazon"@sh
"Rosiglitazon"@sr
"Rosiglitazon"@tr
"Rosiglitazona"@es
"Rosiglitazone"@it
"Rosiglitazone"@vi
"Rosiglitazonă"@ro
"rosiglitason"@cy
"rosiglitazon"@nn
"rosiglitazon"@sl
"rosiglitazona"@pt
"rosiglitazone"@nl
"rosiglitazonum"@la
"Розиглітазон"@uk
"росиглитазон"@ru
"רוזיגליטזון"@he
"روزيجليتازون"@azb
"روسيغليتازون"@ar
"روسیگلیتازون"@fa
"ରୋଜିଗ୍ଲିଟାଜୋନ"@or
"ロシグリタゾン"@ja
"罗格列酮"@zh
"罗格列酮"@zh-cn
"罗格列酮"@zh-hans
"罗格列酮"@zh-sg
"羅格列酮"@zh-hant
"羅格列酮"@zh-hk
"羅格列酮"@zh-tw
|
|
skos:altLabel
|
"(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion"@cy
"(RS)-5-{4-[2-(methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion"@en
"(±)-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione"@cy
"(±)-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione"@en
"5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione"@cy
"5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione"@en
"Avandia"@pt
"Avandia®"@cy
"BRL-49653"@cy
"BRL-49653"@en
"Rosiglitazon"@cy
"Rosiglitazon maleat"@tr
"Rosiglitazona"@cy
"Rosiglitazone"@cy
"Rosiglitazone"@he
"Rosiglitazone"@pt
"Rosiglitazonum"@cy
"rosiglitazone"@en
"rosiglizole"@cy
"rosiglizole"@en
"rozyglitazon"@pl
"梵帝雅"@zh
|
|
schema:description
|
"Gruppe von Stereoisomeren"@de
"group of stereoisomers"@en
"groupe de stréréoisomères"@fr
"grupa stereoizomerów"@pl
"група стереоізомерів"@uk
"группа стереоизомеров"@ru
"معالجات مقاومة الانسولين"@ar
|
|
schema:dateModified
|
"2026-09-04T19:17:52+00:00"^^xsd:dateTime
|
|
schema:version
|
2540214263
|
|
wikibase:identifiers
|
44
|
|
wikibase:sitelinks
|
25
|
|
wikibase:statements
|
71
|
|
p:P10245
|
wd:statement/Q424771-c2b8c2ab-4e33-9a04-45d4-9efb5f615489
|
|
p:P10283
|
wd:statement/Q424771-2144797F-1A47-4920-A0EA-BFD76675C0C6
|
|
p:P11089
|
wd:statement/Q424771-EDF0A239-9C2C-4696-851F-6E5CB4FE3C97
|
|
p:P11143
|
wd:statement/Q424771-AB8169F2-DF57-41FA-B32F-6C67E4444163
|
|
p:P11198
|
wd:statement/Q424771-2134CE12-5C48-41C4-9DC6-B782C181DF87
|
|
p:P11199
|
wd:statement/Q424771-3E4B2334-675B-4133-A6C5-D3FA90321617
|
|
p:P117
|
wd:statement/Q424771-376a79e5-4b02-b951-b43b-8a196cbe5b22
|
|
p:P129
|
wd:statement/Q424771-13B791ED-004A-41BD-A040-31A469EFDE2D
|
|
wd:statement/Q424771-503382B9-43CE-4619-9B69-3DCFE651303D
|
|
wd:statement/Q424771-5B5552DE-32B2-42DA-9072-E6CB17358D7F
|
|
wd:statement/Q424771-EFA45E36-D385-4BDA-A28A-7FF9C8EEBB0C
|
|
p:P13204
|
wd:statement/Q424771-372B3C06-8F2C-404B-9B1A-5748A8DC2EBF
|
|
p:P1417
|
wd:statement/Q424771-70F126DC-D2C4-4F0B-A997-E70B613576CB
|
|
p:P1579
|
wd:statement/Q424771-DBA943A4-CE25-4551-B16F-1FC4EB1785B4
|
|
p:P2057
|
wd:statement/Q424771-4C7768E4-17DD-47CB-AF69-6291E0DDF67C
|
|
p:P2062
|
wd:statement/Q424771-9FE478AD-919A-490E-BF62-5C535C3F42B2
|
|
p:P2067
|
wd:statement/Q424771-02197E67-E681-4FD8-9EF4-F919F2118EFD
|
|
p:P2115
|
wd:statement/Q424771-F345B1F8-E4EF-4BE9-BB48-134FE8135A4A
|
|
p:P2175
|
wd:statement/Q424771-9C855806-A170-4209-A632-30CE51559DFE
|
|
p:P2275
|
wd:statement/Q424771-BBA95A4C-3CD7-41D4-8786-10385B0710D5
|
|
p:P231
|
wd:statement/Q424771-8AEE1AD3-0287-464F-996A-70F65CF0A119
|
|
p:P232
|
wd:statement/Q424771-3D98BCDA-63B9-4FFD-9E44-67804AC4B75F
|
|
p:P233
|
wd:statement/Q424771-9ADB53F8-F1BE-4A2F-886D-3B9273CEB77F
|
|
p:P234
|
wd:statement/Q424771-18C44CDE-752E-46E4-86E2-62ED56654FFC
|
|
p:P235
|
wd:statement/Q424771-7C8A882E-EEE5-4811-818A-97DF8AD8BC19
|
|
p:P2566
|
wd:statement/Q424771-72A54DF9-4CB5-45BD-A98C-0A2C960EC29D
|
|
p:P267
|
wd:statement/Q424771-BC1A7192-7AE9-4E29-B9F8-25D0DE97845D
|
|
p:P274
|
wd:statement/Q424771-9B38C3C3-9CC0-4228-8D81-889794D6F93E
|
|
p:P279
|
wd:statement/Q424771-15DC22E2-5CCA-4D6B-AD9D-00C8A1E0AFA1
|
|
p:P2840
|
wd:statement/Q424771-DC5AEBB0-EFAB-4E08-955F-6098513D440B
|
|
p:P2868
|
wd:statement/Q424771-A4DBA3F5-EB40-48F9-8E8C-D573544B71FC
|
|
p:P2877
|
wd:statement/Q424771-AE31C30F-8697-433C-AFA4-6344B799439D
|
|
p:P2892
|
wd:statement/Q424771-262C9D68-46E0-407C-A7C4-138494961449
|
|
wd:statement/Q424771-A3A6233A-DDEB-4B59-B45E-69B282E941D5
|
|
p:P31
|
wd:statement/Q424771-CFAB2EA8-A65D-4CD9-8288-4DA44C608567
|
|
p:P3117
|
wd:statement/Q424771-59F7F4B6-DAAC-4961-BEF9-90AE59F781F9
|
|
p:P3345
|
wd:statement/Q424771-25794028-3AED-4E95-8089-590D642E91EE
|
|
p:P3350
|
wd:statement/Q424771-acc60214-43a5-c1a0-6546-066368db58a1
|
|
p:P3489
|
wd:statement/Q424771-82C5C2C4-5FDB-408E-A630-19C9C0777CA9
|
|
wd:statement/Q424771-DEA12C6F-7464-47DE-83D9-DAA5D774819F
|
|
p:P366
|
wd:statement/Q424771-4B8AAF72-B42D-45B5-9F03-DD37C813494E
|
|
p:P373
|
wd:statement/Q424771-B3F0CCAB-49F9-46C1-884A-96DDD1BC7C9E
|
|
p:P3780
|
wd:statement/Q424771-375A802C-D56A-4CEE-99F5-3749E3EAFEF7
|
|
wd:statement/Q424771-736E0715-22C4-4E5E-A67C-4EEF4087FA6D
|
|
wd:statement/Q424771-850A3896-DC68-45D9-92EC-3E77DAB4F8DD
|
|
p:P4235
|
wd:statement/Q424771-A420FBA2-2D78-48AC-9253-B988916F424B
|
|
p:P4250
|
wd:statement/Q424771-81BA7B3B-6B57-4D7A-9ECD-B422616867E4
|
|
p:P486
|
wd:statement/Q424771-E0D276B9-2005-41A3-9B4B-E4A5DD2F9108
|
|
p:P4964
|
wd:statement/Q424771-F78578F4-4D50-42B2-8731-F49324A76F3D
|
|
p:P527
|
wd:statement/Q424771-989B8673-2875-43E7-A6DF-28B41A7859D1
|
|
wd:statement/Q424771-9AF85557-E708-41D1-BF52-01691B529252
|
|
p:P592
|
wd:statement/Q424771-5D4BBB54-21E6-47E8-8C7E-3C1B3CD01CC6
|
|
p:P595
|
wd:statement/Q424771-9B356B52-28ED-429F-8962-F4EB9CB4AEE8
|
|
p:P6366
|
wd:statement/Q424771-B38107AF-06B7-41A8-8AD5-35CB853D4703
|
|
p:P646
|
wd:statement/Q424771-43C8EB80-3502-4BEF-97FA-8E1471A85A69
|
|
p:P652
|
wd:statement/Q424771-1599317F-0579-4BBC-BF50-1A8A288E0A58
|
|
p:P661
|
wd:statement/Q424771-2B92FA13-EFB6-4411-A85A-A1B17735E7FD
|
|
p:P662
|
wd:statement/Q424771-67EE9905-3C26-44B7-B3BA-811AE67530E5
|
|
p:P665
|
wd:statement/Q424771-12E99183-F7B6-4E93-A13E-526505972799
|
|
p:P672
|
wd:statement/Q424771-04c938d0-467e-1a93-813a-b300a125a400
|
|
wd:statement/Q424771-be9cf617-4392-d19f-a1b9-07e899b94c55
|
|
p:P683
|
wd:statement/Q424771-50A82D30-A959-4864-8705-77713CDFE920
|
|
p:P703
|
wd:statement/Q424771-271B460B-F26F-420A-A272-CF91BAC06042
|
|
wd:statement/Q424771-58FC2331-5BB8-4AE6-A345-6FE4AED7C8EB
|
|
wd:statement/Q424771-5F222173-CACB-48A6-AE8D-6E897DDCF708
|
|
p:P715
|
wd:statement/Q424771-276EE413-A701-4EB7-A6AE-54FA115D3927
|
|
p:P7746
|
wd:statement/Q424771-6AA02866-07DD-4EA1-BA7A-C9A18B153B74
|
|
p:P7830
|
wd:statement/Q424771-724E0F7C-76A7-484A-A79E-FE4B8058834B
|
|
p:P8026
|
wd:statement/Q424771-D09EBB1D-B38E-4310-A1A8-FC4EAEBC992A
|
|
p:P8494
|
wd:statement/Q424771-F8DE95EB-0CDD-4777-B3BF-CD7262E52D28
|
|
p:P9272
|
wd:statement/Q424771-53406F31-04F7-4043-BA35-9C52533941F8
|
|
p:direct-normalized/P2115
|
<http://purl.bioontology.org/ontology/NDFRT/N0000148613>
|
|
p:direct-normalized/P486
|
<http://id.nlm.nih.gov/mesh/D000077154>
|
|
p:direct-normalized/P592
|
<http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL121>
|
|
p:direct-normalized/P6366
|
<https://makg.org/entity/2780152017>
|
|
p:direct-normalized/P661
|
<http://rdf.chemspider.com/70383>
|
|
p:direct-normalized/P662
|
<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77999>
|
|
p:direct-normalized/P665
|
<http://www.kegg.jp/entry/D00596>
|
|
p:direct-normalized/P672
|
<http://id.nlm.nih.gov/mesh/D02.886.675.933.500>
|
|
<http://id.nlm.nih.gov/mesh/D03.383.129.708.933.500>
|
|
p:direct-normalized/P683
|
<http://purl.obolibrary.org/obo/CHEBI_50122>
|
|
wdt:P10245
|
"a699023"
|
|
wdt:P10283
|
"C2780152017"
|
|
wdt:P11089
|
"7432"
|
|
wdt:P11143
|
"Rosiglitazone"
|
|
wdt:P11198
|
"2405"
|
|
wdt:P11199
|
"PD010041"
|
|
wdt:P117
|
<http://commons.wikimedia.org/wiki/Special:FilePath/Rosiglitazone.svg>
|
|
wdt:P129
|
Peroxisome proliferator activated receptor gamma
|
|
Free fatty acid receptor 1
|
|
Transient receptor potential cation channel subfamily C member 5
|
|
Transient receptor potential cation channel subfamily M member 3
|
|
wdt:P13204
|
"zhu97gyq"
|
|
wdt:P1417
|
"topic/rosiglitazone"
|
|
wdt:P1579
|
"7082202"
|
|
wdt:P2057
|
"HMDB0005031"
|
|
wdt:P2062
|
"7555"
|
|
wdt:P2067
|
357.114712^^xsd:decimal
|
|
wdt:P2115
|
"N0000148613"
|
|
wdt:P2175
|
maturity-onset diabetes of the young type 2
|
|
wdt:P2275
|
"rosiglitazone"@en
|
|
wdt:P231
|
"122320-73-4"
|
|
wdt:P232
|
"924-121-1"
|
|
wdt:P233
|
"CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3"
|
|
wdt:P234
|
"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)"
|
|
wdt:P235
|
"YASAKCUCGLMORW-UHFFFAOYSA-N"
|
|
wdt:P2566
|
"100.108.114"
|
|
wdt:P267
|
"A10BG02"
|
|
wdt:P274
|
"C₁₈H₁₉N₃O₃S"
|
|
wdt:P279
|
glitazone
|
|
wdt:P2840
|
"758698"
|
|
wdt:P2868
|
anti-diabetic medication
|
|
wdt:P2877
|
"5169"
|
|
wdt:P2892
|
"C0289313"
|
|
"C0289314"
|
|
wdt:P31
|
group of stereoisomers
|
|
wdt:P3117
|
"DTXSID7037131"
|
|
wdt:P3345
|
"84108"
|
|
wdt:P3350
|
"7662"
|
|
wdt:P3489
|
US pregnancy category C
|
|
Australian pregnancy category B3
|
|
wdt:P366
|
medication
|
|
wdt:P373
|
"Rosiglitazone"
|
|
wdt:P3780
|
Avandia
|
|
Nyracta
|
|
Venvia
|
|
wdt:P4235
|
"rosiglitazone"
|
|
wdt:P4250
|
6.0^^xsd:decimal
|
|
wdt:P486
|
"D000077154"
|
|
wdt:P4964
|
"splash10-0a4i-0109000000-d527d5c2b5f1de352264"
|
|
wdt:P527
|
carbon
|
|
nitrogen
|
|
wdt:P592
|
"CHEMBL121"
|
|
wdt:P595
|
"1056"
|
|
wdt:P6366
|
"2780152017"
|
|
wdt:P646
|
"/m/02vn54"
|
|
wdt:P652
|
"05V02F2KDG"
|
|
wdt:P661
|
"70383"
|
|
wdt:P662
|
"77999"
|
|
wdt:P665
|
"D00596"
|
|
wdt:P672
|
"D02.886.675.933.500"
|
|
"D03.383.129.708.933.500"
|
|
wdt:P683
|
"50122"
|
|
wdt:P703
|
Penicillium chrysogenum
|
|
Exophiala
|
|
Pseudallescheria boydii
|
|
wdt:P715
|
"DB00412"
|
|
wdt:P7746
|
"NPA035443"
|
|
wdt:P7830
|
"Rosiglitazone"
|
|
wdt:P8026
|
LiverTox toxicity likelihood category C
|
|
wdt:P8494
|
"DTXCID5017131"
|
|
wdt:P9272
|
"57524"
|
